Paclitaxel, foreign exchange among drags on BD's Q4

Still, executives are optimistic about integration of the 2017 acquisition of Bard, set to deliver $100 million in projected fiscal 2020 savings.

By David Lim • Nov. 5, 2019

Stryker goes to extrem(iti)es in $4B Wright Medical takeout

Worth $5.4 billion including debt, the deal dwarfs the K2M buyout and sent shares in extremities device maker Wright Medical soaring almost 30%.

By Maria Rachal • Updated Nov. 4, 2019

Exact Sciences Q3 revenue jumps 85% but Cologuard orders disappoint

Shares in the non-invasive colon cancer test manufacturer fell approximately 6% Wednesday. Exact plans to focus on increasing payer coverage of Cologuard and communicating its label expansion to doctors.

By David Lim • Oct. 30, 2019

UK regulator mulls blocking Illumina's $1.2B PacBio takeover

The watchdog said the union "would result in a significant reduction of competition," leading some analysts to predict the deal won't go through.

By Nick Paul Taylor • Oct. 25, 2019

Merged GTX medical seeks broader footprint in spinal cord stim market

GTX hopes to start clinical studies of an implantable spinal cord stimulation system during 2021, CEO Sjaak Decker told MedTech Dive.

By Dana Elfin • Updated Oct. 22, 2019

Abbott 'working through a handful of items' with FDA on FreeStyle Libre 2

Third-quarter revenue for the medtech came in at $8.08 billion, slightly below Wall Street expectations, but executives praised the growth of key products FreeStyle Libre, MitraClip and Alinity on its earnings call.

By David Lim • Oct. 16, 2019

Qiagen taps new CEO, restructures in 'clearly a bad day'

The company is also suspending next-generation sequencing-related instrument development as it pivots into a 15-year partnership with Illumina to develop in vitro diagnostic kits.

By David Lim • Oct. 8, 2019

Lantheus strikes deal to buy Progenics, sparking investor backlash

Velan Capital, a big shareholder in Progenics, accused management of selling at a "massive discount" and preventing investors from being heard.

By Nick Paul Taylor • Oct. 3, 2019

Medtechs keep shareholders happy, potentially at pipeline's expense: EY

The industry recorded its highest revenues ever within the last year, an analysis by the consultancy shows. Even as R&D spending grew 11%, those investments fell short of the proportion of cash returned to investors.

By Maria Rachal • Sept. 23, 2019

Baxter puts up $230M for noninvasive fluid monitor company

The medtech said it intends to incorporate Cheetah's technology, alongside its IV infusion pumps, IV fluids and medications, into a new integrated platform for patient monitoring now in development.

By Susan Kelly • Sept. 11, 2019

Stryker spends up to $500M to boost spine unit with imaging, robotics tech

The medtech said Monday it completed its buy of Mobius Imaging, which makes a mobile CT scanner, and Cardan Robotics, which develops radiology procedure technologies. 

By Maria Rachal • Updated Oct. 21, 2019

Vertex to buy preclinical biotech for $950M, searching a Type 1 diabetes cure

Semma Therapeutics' drug-device combination product aims to restore insulin secretion. The company has received funding from Medtronic.

By Andrew Dunn • Sept. 3, 2019

Elekta buys ProKnow to boost digital radiotherapy strategy

The Swedish company says ProKnow's capabilities are of particular value to its large customers, potentially helping give it an edge over rivals such as Varian Medical Systems.

By Nick Paul Taylor • Aug. 29, 2019

Boston Scientific closes acquisition of BTG

The medtech giant is betting that having the subsidiary will make it the "category leader" in interventional oncology tools and products.  

By Maria Rachal • Updated Aug. 19, 2019

Stryker acquires maker of device sterilization systems

The deal comes against a backdrop of heightened regulatory scrutiny of duodenoscope reprocessing after a spike in contamination cases and the closure of a Sterigenics​ plant in Illinois that sterilized a wide range of devices.

By Susan Kelly • Aug. 13, 2019

AFib device maker AtriCure to spend up to $300M in SentreHeart buyout

AtriCure announced Tuesday it completed its acquisition of SentreHeart.

By Maria Rachal • Updated Aug. 14, 2019

Siemens acquires Corindus Vascular Robotics for $1.1B

The now-completed takeover gives Siemens Healthineers an FDA-cleared and CE-marked system for endovascular coronary and peripheral vascular interventions.

By David Lim • Updated Oct. 29, 2019

Hill-Rom picks up wearable ventilator maker in $130M deal

The medical equipment and systems company announced it's adding Breathe Technologies to its respiratory care business, part of a unit that contributed to Hill-Rom's 3% quarterly revenue growth reported Friday.

By Maria Rachal • Aug. 2, 2019

Exact Sciences to gain breast, prostate cancer tests in $2.8B deal

The Cologuard maker is adding Genomic Health's Oncotype DX tests to its ranks, which together target a market worth an estimated $20 billion.

By Maria Rachal • July 29, 2019

Healthcare the lone growth driver for 3M in Q2

The unit posted 5.8% sales growth, providing some relief for the beleaguered conglomerate, which expects its $6.7 billion buyout of wound care company Acelity to close in the fourth quarter.

By Nick Paul Taylor • July 26, 2019

Quest reports volume growth despite loss of contracts

Executives at the lab testing giant disclosed it lost a few capitated contracts open for renewal during the second quarter due to a competitor offering lower rates than were profitable.

By David Lim • July 23, 2019

Intuitive buys Schölly's robotic endoscope business

The deal will give the robotic surgery giant control of the German company's minimally invasive visualization systems, 200 staff and three sites.

By Nick Paul Taylor • July 16, 2019

Hill-Rom to sell surgical consumables unit for $170M

The transaction will free Hill-Rom​ of a stagnant business and its 500 employees, while giving it more cash to spend on acquisitions.

By Nick Paul Taylor • July 11, 2019

Varian, Boston Scientific seal the deal on beads business transfer

Varian Medical Systems said Wednesday it completed the $90 million purchase of Boston Scientific's drug-loadable microspheres and bland embolic beads, a transaction key to Boston Scientific's buyout of BTG finalized Monday.

By Maria Rachal • Updated Aug. 21, 2019

As digital health investing matures, report says sector dodges a bubble

Venture fund and research firm Rock Health said the pace of investment dollars flowing into the sector may top 2018’s record funding as a digital health IPO drought appears on the verge of ending.

By Susan Kelly • July 2, 2019